Law Daily Report

Novartis halts study of iscalimab in kidney transplant patients

  • 📰 Reuters
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 97%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

Novartis has halted a clinical trial of CFZ533 (iscalimab) in kidney transplant patients after interim data showed it was not as good as tacrolimus-based treatment in preventing organ rejection, the Swiss group said on Friday.

The company's logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November 28, 2019. REUTERS/Arnd Wiegmann/File Photohas halted a clinical trial of CFZ533 in kidney transplant patients after interim data showed it was not as good as tacrolimus-based treatment in preventing organ rejection, the Swiss group said on Friday.

Its study of the medicine in liver transplant continues, as do studies exploring it as a potential treatment in other conditions,

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

did you misspell islamabad?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Texas' new abortion law could have huge consequences. Here's what comes next.A new Texas abortion law that went to effect on Wednesday is only the latest effort by a Republican-led state to curtail abortion rights, but what the U.S. Supreme Court does next could have sweeping implications nationwide. Serious question, Doesn't the Taliban regulate women's rights? Texas now becomes more of a butthole than Florida was….quite an achievement.
Source: NBCNews - 🏆 10. / 86 Read more »